Indian Pharmaceuticals & Biotech Stable Growth Stocks

Ajanta Pharma

Market Cap: ₹462.0b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Emcure Pharmaceuticals

Market Cap: ₹358.5b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Neuland Laboratories

Market Cap: ₹298.9b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹264.4b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Granules India

Market Cap: ₹207.7b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

Lupin

Market Cap: ₹1.0t

Operates as a pharmaceutical company in India, the United States, and internationally.

Ipca Laboratories

Market Cap: ₹483.0b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.

Aether Industries

Market Cap: ₹217.7b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Sai Life Sciences

Market Cap: ₹301.7b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Aurobindo Pharma

Market Cap: ₹934.7b

A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.

Abbott India

Market Cap: ₹561.0b

Operates as a pharmaceutical company in India.

Rubicon Research

Market Cap: ₹297.8b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Anthem Biosciences

Market Cap: ₹496.7b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹514.0b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.

Biocon

Market Cap: ₹668.5b

Manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.